Ocular Allergy

What clinicians should know about ocular allergies

March 15, 2016

The arrival of spring also signals the onset of ocular allergy season. Clinicians can prepare by knowing and recognizing the symptoms in their patients, as well as being informed about the latest therapies for this diagnosis.

Getting to the root cause of ocular allergy

March 15, 2016

Being armed with as much information as possible about a patient’s ocular allergies can make a major difference in treatment decisions, whether for dry eye or scheduling of ocular surgery.

What punctal plug delivery of dexamethasone means for allergic conjunctivitis

March 15, 2016

Treatment of chronic allergic conjunctivitis with a sustained-release dexamethasone resulted in better clinical results because of the sustained and controlled delivery.

Allergy or dry eye: Which is it?

March 15, 2016

Ocular surface disease may be multifactorial, presenting a challenge to the physician in making a correct diagnosis and management plan.

Dual-acting, anti-allergy agent delivers efficacy, safety, convenience

February 15, 2015

Olopatadine 0.2% is a well-tolerated, safe, and effective antihistamine/mast cell stabilizer for treating mild to severe allergic conjunctivitis in children and adults.

Novel dexamethasone punctum plug for ocular allergy shows promise

February 15, 2015

A novel dexamethasone-eluting punctum plug was safe and showed some evidence of efficacy for relieving signs and symptoms of allergic conjunctivitis in a phase II study.

Anti-allergic agent alcaftadine stronger in relief of ocular itching

February 15, 2015

In head-to-head clinical assessments, alcaftadine was found to be statistically and clinically superior to olopatadine for relief of allergic conjunctivitis.

Immunotherapy: Does it play a role in ocular allergy?

February 15, 2014

Numerous clinical trials are under way that may help to define the role of immunotherapy in ocular allergy.